We are excited to share a major milestone for the STXBP1 community: Capsida Biotherapeutics has received FDA clearance to begin […]
Rare Disease Month, culminating in Rare Disease Day on February 28 this year, is an important time for the rare
The European STXBP1 Consortium (ESCO) is excited to share groundbreaking news in the quest for new treatments for STXBP1 disorders!
The 2025 STXBP1 Summit, hosted by the European STXBP1 Consortium (ESCO), takes place in Heidelberg, Germany. This event, scheduled from
The European STXBP1 Consortium (ESCO) is thrilled to announce that it has secured the necessary funding to commence its large
On Saturday June 8, 2024, Dutch and Belgian teams including members from the European STXBP1 Consortium successfully biked the European
Research teams from ESCO member institutes in the Netherlands and Belgium are preparing to participate in the European satellite event
Representatives from ESCO’s eight member countries convened in Antwerp, Belgium, on February 8th, marking the initiation of ESCO’s strategic endeavours
AUMC and VU have worked together with industry to develop animal and human disease models for STXBP1-RD and to design
The first european STXBP1 summit and research roundtable will take place from 16-18th of May in Milan. With this first
